Could a new vaccine spell the end of HIV/Aids?
|
The injection contains an antiretroviral drug,
Cabotegravir, which is released in the body over a two-month period. While
this solution is promising, ... |
Impact of US funding cuts on HIV programmes in Angola
While stocks of antiretroviral supplies, HIV, viral load and other lab test kits are available, recent reports indicate challenges with distribution. View article...